Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Cardiology Cardiac Arrhythmia

Cardiac Arrhythmia

Total AV block as a cardiac manifestation of Weil’s disease

Weil’s disease is a zoonotic infection which may cause arrhythmias. This fatal case of total AV block induced by leptospirosis is a warning of the importance of early, and accurate, diagnosis and treatment of this infection. 

Read more

Editor's Choice

CV effects of antiseizure medications for epilepsy

Antiseizure medications can adversely affect lipid profiles and cause cardiac arrhythmias, increasing cardiovascular morbidity and mortality. How can you identify patients at risk and when to intervene?

Rare complication of Kawasaki disease

Kawasaki disease rarely causes arrhythmias, but this infant was diagnosed with supraventricular tachycardia, which resolved after combination treatment with intravenous immunoglobulin and steroids.

Pausing AF DOACs before minor procedures results in low bleeding rates

Lower rates of major bleeding in patients with AF when factor Xa inhibitor treatment is paused 24 hours before procedures with minor bleed risk.

Abelacimab lowers risk for bleeding compared with rivaroxaban in AF

Abelacimab treatment results in fewer bleeding events than rivaroxaban in patients with atrial fibrillation and a moderate-to-high stroke risk.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Latest News

The earlier the better for DOAC initiation in stroke patients with AF

Decreased stroke risk with DOAC may be offset by increased chance of bleeding

Pausing AF DOACs before minor procedures results in low bleeding rates

Apixaban benefit over aspirin greater in atrial fibrillation patients with stroke history

Abelacimab lowers risk for bleeding compared with rivaroxaban in AF

Partial cardiac denervation may reduce AF after CABG

Case Studies

Total AV block as a cardiac manifestation of Weil’s disease

Weil’s disease is a zoonotic infection which may cause arrhythmias. This fatal case of total AV block induced by leptospirosis is a warning of the importance of early, and accurate, diagnosis and treatment of this infection. 

Rare complication of Kawasaki disease

Kawasaki disease rarely causes arrhythmias, but this infant was diagnosed with supraventricular tachycardia, which resolved after combination treatment with intravenous immunoglobulin and steroids.

Myocarditis in a complex postpartum adolescent

An 18-year-old postpartum patient is admitted with concomitant acute myocarditis and congenital long QT syndrome with electrical storm and incessant Torsade de Pointes. What would your management strategy be?

Episode 3: Unravelling resistant hypertension

Why is it so difficult to diagnose and manage?

Resistant hypertension is a difficult to treat and often misunderstood phenomenon that continues to frustrate cardiologists. 

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options.

Prof. Morris Brown
Prof. Bryan Williams
Listen now
Podcast

Current Reviews

Retinal Ischemic Perivascular Lesions (RIPLs) as Potential Biomarkers for Systemic Vascular Diseases: A Narrative Review of the Literature

Retinal ischemic perivascular lesions (RIPLs) are characteristic focal thinning of the inner nuclear layer, with an upward expansion of the outer nuclear layer identified by spectral domain optical coherence tomography (SD-OCT), causing a focal …

Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions

Atrial fibrillation is the most common cardiac arrhythmia and is a major risk factor for ischemic stroke. Atrial fibrillation and ischemic stroke are major cardiovascular complications in cancer patients, who have a higher burden and worse …

Appraisal of β-Blocker Use in Patients with Cardiovascular Disease and Chronic Obstructive Pulmonary Disease

β-blockers are a fundamental component of cardiovascular disease (CVD) management, while β2-agonists are used to treat chronic obstructive pulmonary disease (COPD). Current guidelines recommend that these conditions be treated as usual, even when …

Combined Catheter Ablation and Left Atrial Appendage Occlusion in Atrial Fibrillation: From Data to Clinical Reality

Atrial fibrillation (AF), the most common cardiac arrhythmia, is well-known for its threatening complications, with the most significant being ischemic stroke. While the stroke risk is usually managed with oral anticoagulant treatment (OAC) …

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Watch now
Video

Further Reading

Retinal Ischemic Perivascular Lesions (RIPLs) as Potential Biomarkers for Systemic Vascular Diseases: A Narrative Review of the Literature

Retinal ischemic perivascular lesions (RIPLs) are characteristic focal thinning of the inner nuclear layer, with an upward expansion of the outer nuclear layer identified by spectral domain optical coherence tomography (SD-OCT), causing a focal …

Effects of the ABC pathway on clinical outcomes in very elderly Chinese patients with atrial fibrillation. A report from the optimal thromboprophylaxis in elderly Chinese patients with atrial fibrillation (ChiOTEAF) registry

The current Atrial fibrillation Better Care (ABC) pathway for holistic or integrated management of AF is associated with improved clinical outcomes; however, data on the very elderly (aged ≥ 85 years) are sparse.To evaluate the impact of ABC …

Long-term outcome after multiple VT ablations in NICM patients

Catheter ablation (CA) has been shown to represent an effective treatment option of sustained ventricular tachycardia (VT) in structural heart disease (SHD), irrespective of ischemic (ICM) or non-ischemic (NICM) origin [ 1 , 2 ]. VT ablation can …

Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease

Defibrillation threshold (DFT) testing, defined as the minimum energy required to successfully terminate ventricular fibrillation (VF) at the time of transvenous left-sided implantable cardioverter-defibrillators (ICD), is no longer routinely …

Image Credits